The approach, the first of its kind, takes advantage of induced pluripotent stem cell technology to transform skin cells into retinal cells, which are then used as a patient-specific model for disease study and preclinical testing.
from News Nation http://ift.tt/1ovFtwh
via IFTTT
from News Nation http://ift.tt/1ovFtwh
via IFTTT
No comments:
Post a Comment